Which mode of transmission is associated with hepatitis A?

Choice A rationale:

Advising the patient to avoid alcohol and hepatotoxic drugs is appropriate because in hepatitis A, the liver is already inflamed and compromised. Alcohol and hepatotoxic drugs can further damage the liver and impede the healing process. It is essential to protect the liver from further harm during recovery.

Choice B rationale:

The patient has hepatitis A, not hepatitis C, so there is no need for the hepatitis C vaccine. The hepatitis A vaccine is available for prevention, not the hepatitis C vaccine.

Choice C rationale:

While monitoring liver function is essential for individuals with liver disease, this statement is not specifically relevant to the patient with hepatitis

A. Monitoring liver function is more critical for chronic liver diseases like hepatitis B and C.

Choice D rationale:

Antiviral therapy is not indicated for hepatitis A since the infection usually resolves on its own. This statement is not appropriate for the patient with hepatitis

A.

A.

Choice A rationale:

Choice A is incorrect because the hepatitis A vaccine provides active immunity, not passive immunity. Active immunity means that the body produces its antibodies in response to the vaccine, providing long-term protection against the virus.

Choice B rationale:

The hepatitis A vaccine is indeed recommended for travelers to areas with high prevalence of hepatitis

A. It helps protect travelers from acquiring the virus through contaminated food and water in regions where hepatitis A is more common.

Choice C rationale:

Choice C is incorrect because the hepatitis A vaccine is effective in preventing hepatitis A in close contacts of infected individuals. Vaccination is a crucial preventive measure for those who are in close contact with infected individuals, as it can help halt the spread of the virus.

Choice D rationale:

Choice D is incorrect because the hepatitis A vaccine is not given within 12 hours of birth to newborns of hepatitis A positive mothers. The vaccination schedule for hepatitis A vaccine varies depending on the country's recommendations but is typically given starting at 12-23 months of age.